These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 16988455

  • 1. Prime-boost strategies in DNA vaccines.
    Dale CJ, Thomson S, De Rose R, Ranasinghe C, Medveczky CJ, Pamungkas J, Boyle DB, Ramshaw IA, Kent SJ.
    Methods Mol Med; 2006; 127():171-97. PubMed ID: 16988455
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.
    Ranasinghe C, Medveczky JC, Woltring D, Gao K, Thomson S, Coupar BE, Boyle DB, Ramsay AJ, Ramshaw IA.
    Vaccine; 2006 Jul 26; 24(31-32):5881-95. PubMed ID: 16759767
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S, Feng X, Shu T, Matano T, Hasegawa M, Wang X, Ma H, Li H, Li Z, Zeng Y.
    Vaccine; 2008 Nov 11; 26(48):6124-31. PubMed ID: 18812199
    [Abstract] [Full Text] [Related]

  • 5. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
    Cristillo AD, Wang S, Caskey MS, Unangst T, Hocker L, He L, Hudacik L, Whitney S, Keen T, Chou TH, Shen S, Joshi S, Kalyanaraman VS, Nair B, Markham P, Lu S, Pal R.
    Virology; 2006 Mar 01; 346(1):151-68. PubMed ID: 16325880
    [Abstract] [Full Text] [Related]

  • 6. Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials.
    Coupar BE, Purcell DF, Thomson SA, Ramshaw IA, Kent SJ, Boyle DB.
    Vaccine; 2006 Feb 27; 24(9):1378-88. PubMed ID: 16257479
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E, Mathy N, Bråve A, Boberg A, Kjerrström A, van Wely C, Engström G, Johansson S, Aperia K, Eriksson LE, Benthin R, Ertl P, Heeney J, Hinkula J, Voss G, Wahren B.
    Vaccine; 2007 Mar 01; 25(11):2145-54. PubMed ID: 17254672
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ, Dale CJ, Ranasinghe C, Stratov I, De Rose R, Chea S, Montefiori DC, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Law M, Wilson KM, Ramsay AJ.
    Vaccine; 2005 Oct 10; 23(42):5009-21. PubMed ID: 15985317
    [Abstract] [Full Text] [Related]

  • 11. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.
    Huang X, Liu L, Ren L, Qiu C, Wan Y, Xu J.
    Vaccine; 2007 Dec 17; 25(52):8874-84. PubMed ID: 18061316
    [Abstract] [Full Text] [Related]

  • 12. Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques.
    De Rose R, Chea S, Dale CJ, Reece J, Fernandez CS, Wilson KM, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Sullivan MT, Kent SJ.
    Vaccine; 2005 Mar 14; 23(16):1949-56. PubMed ID: 15734067
    [Abstract] [Full Text] [Related]

  • 13. Comparison of whole gene and whole virus scrambled antigen approaches for DNA prime and fowlpox virus boost HIV type 1 vaccine regimens in macaques.
    Pamungkas J, De Rose R, Iskandriati D, Noviana R, Paramastri Y, Dale CJ, Shoobridge M, Medveczky CJ, Ramshaw IA, Thomson S, Kent SJ.
    AIDS Res Hum Retroviruses; 2005 Apr 14; 21(4):292-300. PubMed ID: 15943571
    [Abstract] [Full Text] [Related]

  • 14. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus.
    Kent SJ, Zhao A, Best SJ, Chandler JD, Boyle DB, Ramshaw IA.
    J Virol; 1998 Dec 14; 72(12):10180-8. PubMed ID: 9811759
    [Abstract] [Full Text] [Related]

  • 15. Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant.
    Bråve A, Johansen K, Palma P, Benthin R, Hinkula J.
    Vaccine; 2008 Nov 05; 26(47):5957-66. PubMed ID: 18801400
    [Abstract] [Full Text] [Related]

  • 16. Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.
    Xin KQ, Jounai N, Someya K, Honma K, Mizuguchi H, Naganawa S, Kitamura K, Hayakawa T, Saha S, Takeshita F, Okuda K, Honda M, Klinman DM, Okuda K.
    Gene Ther; 2005 Dec 05; 12(24):1769-77. PubMed ID: 16079886
    [Abstract] [Full Text] [Related]

  • 17. Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles.
    Sundbäck M, Douagi I, Dayaraj C, Forsell MN, Nordström EK, McInerney GM, Spångberg K, Tjäder L, Bonin E, Sundström M, Liljeström P, Karlsson Hedestam GB.
    Virology; 2005 Oct 25; 341(2):190-202. PubMed ID: 16098555
    [Abstract] [Full Text] [Related]

  • 18. DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.
    Buonaguro L, Devito C, Tornesello ML, Schröder U, Wahren B, Hinkula J, Buonaguro FM.
    Vaccine; 2007 Aug 10; 25(32):5968-77. PubMed ID: 17629365
    [Abstract] [Full Text] [Related]

  • 19. Prime-boost immunization with DNA, recombinant fowlpox virus and VLP(SHIV) elicit both neutralizing antibodies and IFNgamma-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells.
    Radaelli A, Bonduelle O, Beggio P, Mahe B, Pozzi E, Elli V, Paganini M, Zanotto C, De Giuli Morghen C, Combadière B.
    Vaccine; 2007 Mar 01; 25(11):2128-38. PubMed ID: 17241705
    [Abstract] [Full Text] [Related]

  • 20. Immunization of neonatal mice with LAMP/p55 HIV gag DNA elicits robust immune responses that last to adulthood.
    Rigato PO, Maciel M, Goldoni AL, Piubelli O, de Brito CA, Fusaro AE, Eurico de Alencar LX, August T, Azevedo Marques ET, da Silva Duarte AJ, Sato MN.
    Virology; 2010 Oct 10; 406(1):37-47. PubMed ID: 20667577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.